{
    "organizations": [],
    "uuid": "d28b14c774ea60f882af4cb5b5a47c70c0750451",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alnylam-pharmaceuticals-says-on-ma/brief-alnylam-pharmaceuticals-says-on-may-12-cos-board-expanded-size-of-board-from-ten-to-eleven-idUSFWN1SM1F4",
    "ord_in_thread": 0,
    "title": "BRIEF-Alnylam Pharmaceuticals Says On May 12, Co's Board Expanded Size Of Board From Ten To Eleven",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Alnylam Pharmaceuticals Inc:\n* ALNYLAM PHARMACEUTICALS INC SAYS ON MAY 12, CO'S BOARD EXPANDED SIZE OF BOARD FROM TEN TO ELEVEN - SEC FILING Source bit.ly/2KrXrlM Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T05:25:00.000+03:00",
    "crawled": "2018-05-16T19:17:22.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "alnylam",
        "pharmaceutical",
        "inc",
        "alnylam",
        "pharmaceutical",
        "inc",
        "say",
        "may",
        "co",
        "board",
        "expanded",
        "size",
        "board",
        "ten",
        "eleven",
        "sec",
        "filing",
        "source",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}